BUNKER KEVIN D. (Chief Operating Officer) sold 84.2% of their position (80K shares) of ZENTALIS PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $2.40M — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 5/31/2023ACC: 0001725160-23-000124
Officer· Chief Operating Officer
Since Apr 2020
-80K
Net shares
Net seller
$2.40M
Total sold
1
Open market trades
0B · 1S
1
Total transactions
80K disposed
Non-Derivative Transactions1
Common Stock
Indirect
Shares
−80K
Price / share
$30.02
Trade value
$2.40M
% of position
84.2%
5/26/2023
95K→15K
Total
Net shares
−80K
Net value
-$2.40M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 5/26/2023 | S · Sale | −80K | $30.02 | $2.40M | 84.2% | 95K | 15K |
| Total | −80K | -$2.40M | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)2
Common Stock
DirectShares owned865.16K
Common Stock
IndirectShares owned350.00
Total
865.16K direct·350.00 indirect865.51K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 865.16K | Direct |
| Common Stock | 350.00 | Indirect |
| Total | 865.51K | 865.16K direct·350.00 indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported